MASP1

Chr 3AR

MBL associated serine protease 1

Also known as: 3MC1, CRARF, CRARF1, MAP-1, MAP1, MASP, MASP-3, MASP3

This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.981 OMIM phenotype
Clinical SummaryMASP1
🧬
Gene-Disease Validity (ClinGen)
3MC syndrome 1 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 193 VUS of 406 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.98LOEUF
pLI 0.000
Z-score 1.66
OE 0.68 (0.490.98)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.16Z-score
OE missense 1.02 (0.941.11)
401 obs / 392.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.68 (0.490.98)
00.351.4
Missense OE?1.02 (0.941.11)
00.61.4
Synonymous OE?1.16
01.21.6
LoF obs/exp: 22 / 32.1Missense obs/exp: 401 / 392.1Syn Z: -1.55
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMASP1-related 3MC syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6453th %ile
GOF
0.7027th %ile
LOF
0.3065th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

406 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic11
VUS193
Likely Benign106
Benign58
Conflicting17
15
Pathogenic
11
Likely Pathogenic
193
VUS
106
Likely Benign
58
Benign
17
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
4
1
0
15
Likely Pathogenic
8
3
0
0
11
VUS
3
188
2
0
193
Likely Benign
0
13
43
50
106
Benign
0
4
46
8
58
Conflicting
17
Total212129258400

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

41 pathogenic / likely-pathogenic (of 43) ClinVar copy-number / structural variants overlap MASP1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MASP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →